Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome

Background Postural orthostatic tachycardia syndrome (POTS) is characterized by excessive heart rate increase on standing and orthostatic intolerance. Previous data indicate autoimmune involvement. We studied serum activity against G protein–coupled receptors in relation to symptoms in patients with...

Full description

Bibliographic Details
Main Authors: Isabella Kharraziha, Jonas Axelsson, Fabrizio Ricci, Giuseppe Di Martino, Margaretha Persson, Richard Sutton, Artur Fedorowski, Viktor Hamrefors
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.015989
_version_ 1818775135823331328
author Isabella Kharraziha
Jonas Axelsson
Fabrizio Ricci
Giuseppe Di Martino
Margaretha Persson
Richard Sutton
Artur Fedorowski
Viktor Hamrefors
author_facet Isabella Kharraziha
Jonas Axelsson
Fabrizio Ricci
Giuseppe Di Martino
Margaretha Persson
Richard Sutton
Artur Fedorowski
Viktor Hamrefors
author_sort Isabella Kharraziha
collection DOAJ
description Background Postural orthostatic tachycardia syndrome (POTS) is characterized by excessive heart rate increase on standing and orthostatic intolerance. Previous data indicate autoimmune involvement. We studied serum activity against G protein–coupled receptors in relation to symptoms in patients with POTS and controls using a commercial cell‐based assay. Methods and Results Forty‐eight patients with POTS (aged 28.6±10.5 years; 44 women) and 25 healthy individuals (aged 30.7±8.6 years; 21 women) were included. The 10‐item Orthostatic Hypotension Questionnaire (OHQ) was completed by 33 patients with POTS and all controls. Human embryonic kidney 293 cells overexpressing one G protein–coupled receptor: adrenergic α1 receptor, adrenergic β2 receptor, cholinergic muscarinic type 2 receptor, and opioid receptor‐like 1 were treated with sera from all patients. Receptor response was analyzed using a β‐arrestin–linked transcription factor driving transgenic β‐lactamase transcription by fluorescence resonance energy transfer method. Receiver operating characteristic curves were constructed. G protein–coupled receptor activation was related to OHQ indices in linear regression models. Sera from patients with POTS activated all 4 receptors to a higher degree compared with controls (P<0.01 for all). The area under the curve was 0.88 (0.80–0.97, P<0.001) combining all 4 receptors. Adrenergic α1 receptor activation associated with OHQ composite score (β=0.77 OHQ points per SD of activity, P=0.009) and with reduced tolerability for prolonged standing (P=0.037) and walking for short (P=0.042) or long (P=0.001) periods. All 4 receptors were associated with vision problems (P<0.05 for all). Conclusions Our results indicate the presence of circulating proteins activating adrenergic, muscarinic, and nociceptin receptors in patients with POTS. Serum‐mediated activation of these receptors has high predictive value for POTS. Activation of adrenergic α1 receptor is associated with orthostatic symptoms severity in patients with POTS.
first_indexed 2024-12-18T10:52:14Z
format Article
id doaj.art-a3ee25a06b494360984c17add84d04f4
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-18T10:52:14Z
publishDate 2020-08-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-a3ee25a06b494360984c17add84d04f42022-12-21T21:10:26ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-08-0191510.1161/JAHA.120.015989Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia SyndromeIsabella Kharraziha0Jonas Axelsson1Fabrizio Ricci2Giuseppe Di Martino3Margaretha Persson4Richard Sutton5Artur Fedorowski6Viktor Hamrefors7Department of Clinical Sciences Lund University Malmö SwedenDepartment of Stem Cell Therapy and Apheresis Karolinska University Hospital Stockholm SwedenDepartment of Clinical Sciences Lund University Malmö SwedenDepartment of Medicine and Ageing Sciences "G. d'Annunzio" University Chieti ItalyDepartment of Clinical Sciences Lund University Malmö SwedenDepartment of Clinical Sciences Lund University Malmö SwedenDepartment of Clinical Sciences Lund University Malmö SwedenDepartment of Clinical Sciences Lund University Malmö SwedenBackground Postural orthostatic tachycardia syndrome (POTS) is characterized by excessive heart rate increase on standing and orthostatic intolerance. Previous data indicate autoimmune involvement. We studied serum activity against G protein–coupled receptors in relation to symptoms in patients with POTS and controls using a commercial cell‐based assay. Methods and Results Forty‐eight patients with POTS (aged 28.6±10.5 years; 44 women) and 25 healthy individuals (aged 30.7±8.6 years; 21 women) were included. The 10‐item Orthostatic Hypotension Questionnaire (OHQ) was completed by 33 patients with POTS and all controls. Human embryonic kidney 293 cells overexpressing one G protein–coupled receptor: adrenergic α1 receptor, adrenergic β2 receptor, cholinergic muscarinic type 2 receptor, and opioid receptor‐like 1 were treated with sera from all patients. Receptor response was analyzed using a β‐arrestin–linked transcription factor driving transgenic β‐lactamase transcription by fluorescence resonance energy transfer method. Receiver operating characteristic curves were constructed. G protein–coupled receptor activation was related to OHQ indices in linear regression models. Sera from patients with POTS activated all 4 receptors to a higher degree compared with controls (P<0.01 for all). The area under the curve was 0.88 (0.80–0.97, P<0.001) combining all 4 receptors. Adrenergic α1 receptor activation associated with OHQ composite score (β=0.77 OHQ points per SD of activity, P=0.009) and with reduced tolerability for prolonged standing (P=0.037) and walking for short (P=0.042) or long (P=0.001) periods. All 4 receptors were associated with vision problems (P<0.05 for all). Conclusions Our results indicate the presence of circulating proteins activating adrenergic, muscarinic, and nociceptin receptors in patients with POTS. Serum‐mediated activation of these receptors has high predictive value for POTS. Activation of adrenergic α1 receptor is associated with orthostatic symptoms severity in patients with POTS.https://www.ahajournals.org/doi/10.1161/JAHA.120.015989adrenergic receptorsautoimmunityG protein–coupled receptorsorthostatic intolerancepostural orthostatic tachycardia syndrome
spellingShingle Isabella Kharraziha
Jonas Axelsson
Fabrizio Ricci
Giuseppe Di Martino
Margaretha Persson
Richard Sutton
Artur Fedorowski
Viktor Hamrefors
Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
adrenergic receptors
autoimmunity
G protein–coupled receptors
orthostatic intolerance
postural orthostatic tachycardia syndrome
title Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome
title_full Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome
title_fullStr Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome
title_full_unstemmed Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome
title_short Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome
title_sort serum activity against g protein coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome
topic adrenergic receptors
autoimmunity
G protein–coupled receptors
orthostatic intolerance
postural orthostatic tachycardia syndrome
url https://www.ahajournals.org/doi/10.1161/JAHA.120.015989
work_keys_str_mv AT isabellakharraziha serumactivityagainstgproteincoupledreceptorsandseverityoforthostaticsymptomsinposturalorthostatictachycardiasyndrome
AT jonasaxelsson serumactivityagainstgproteincoupledreceptorsandseverityoforthostaticsymptomsinposturalorthostatictachycardiasyndrome
AT fabrizioricci serumactivityagainstgproteincoupledreceptorsandseverityoforthostaticsymptomsinposturalorthostatictachycardiasyndrome
AT giuseppedimartino serumactivityagainstgproteincoupledreceptorsandseverityoforthostaticsymptomsinposturalorthostatictachycardiasyndrome
AT margarethapersson serumactivityagainstgproteincoupledreceptorsandseverityoforthostaticsymptomsinposturalorthostatictachycardiasyndrome
AT richardsutton serumactivityagainstgproteincoupledreceptorsandseverityoforthostaticsymptomsinposturalorthostatictachycardiasyndrome
AT arturfedorowski serumactivityagainstgproteincoupledreceptorsandseverityoforthostaticsymptomsinposturalorthostatictachycardiasyndrome
AT viktorhamrefors serumactivityagainstgproteincoupledreceptorsandseverityoforthostaticsymptomsinposturalorthostatictachycardiasyndrome